MedTrace Logo

Relationship of Eye Colour With Anesthetic Success and Post-Operative Pain

NCT06206304 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 110

Last updated 2024-05-29

No results posted yet for this study

Summary

Current evidence indicates that some phenotypic characteristics, such as eye or hair color, might be associated with the experience of pain. We therefore compared the anaesthetic success rate of inferior alveolar nerve block (IANB), and post-operative pain scores between light and dark eyed in female patients experiencing symptomatic irreversible pulpitis (SIP) in a mandibular molar.

110 adult patients, experiencing moderate or severe pain with SIP, participated in this prospective study. All patients received IANB of 4% articaine with 1:100.000 epinephrine. Endodontic access cavity preparation was initiated after confirmed of IANB with numbness of the lower lip. Pain during treatment was recorded by using a Heft Parker Visual Analog Scale. Anaesthetic success was recorded as ''none'' or ''mild'' pain. Root canal treatment was performed, with standardized protocols. Post-operative pain scores were also recorded 24, 48, 72 hours and 7 days after treatment.

Conditions

  • Post-operative Pain
  • Irreversible Pulpitis

Interventions

OTHER

Root canal therapy

Traditional root canal therapy was performed with rubber-dam isolation.

Sponsors & Collaborators

  • Mustafa Kemal University

    lead OTHER

Principal Investigators

  • Merve Sarı, DDS · Mustafa Kemal University

  • Koray Yılmaz, DDS,MSc · Cukurova University

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-06-18
Primary Completion
2023-12-04
Completion
2023-12-11

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06206304 on ClinicalTrials.gov